Menu Search
Equities

Foxo Technologies Inc

FOXO:ASQ

Foxo Technologies Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.1741
  • Today's Change0.003 / 1.81%
  • Shares traded69.00
  • 1 Year change-84.55%
  • Beta1.9886
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Foxo Technologies Inc had revenues fall -71.62% from 511.00k to 145.00k, though the company grew net income from a loss of 95.26m to a smaller loss of 26.45m.
Gross margin-9.68%
Net profit margin-7,217.42%
Operating margin-6,425.16%
Return on assets-204.27%
Return on equity--
Return on investment--
More ▼

Cash flow in USDView more

In 2023, cash reserves at Foxo Technologies Inc fell by 5.48m. Cash Flow from Financing totalled 1.17m or 805.52% of revenues. In addition the company used 6.65m for operations while cash from investing was breakeven.
Cash flow per share-1.61
Price/Cash flow per share--
Book value per share-1.43
Tangible book value per share-1.85
More ▼

Balance sheet in USDView more

Foxo Technologies Inc uses little or no debt in its capital structure.
Current ratio0.023
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.